{"AllianceGenome": "800", "HGNC": "800", "MIM": "182340", "_id": "477", "_version": 1, "accession": {"genomic": ["AH001424.2", "AL121987.34", "CH471121.2", "CP068277.2", "J05096.1", "NC_000001.11", "NC_060925.1", "NG_008014.1"], "protein": ["AAA35575.1", "AAA51797.1", "AAA51799.1", "AAH52271.2", "AAX55909.1", "ALQ33385.1", "ALQ33386.1", "BAA34498.3", "BAG36951.1", "BAG52393.1", "BAG54055.1", "BAG54347.1", "BAG58098.1", "BAG58570.1", "BAG61427.1", "CAA68793.1", "EAW52739.1", "EAW52740.1", "EAW52741.1", "EAW52742.1", "NP_000693.1", "P50993.1", "XP_047277242.1", "XP_054192734.1"], "rna": ["AB018321.2", "AK091617.1", "AK124581.1", "AK126573.1", "AK295048.1", "AK295729.1", "AK299460.1", "AK308773.1", "AK314296.1", "AL831991.1", "AL831997.1", "AY946014.1", "BC013680.1", "BC047533.1", "BC052271.1", "DA221602.1", "EB386326.1", "KU177927.1", "KU177928.1", "M16795.1", "NM_000702.4", "XM_047421286.1", "XM_054336759.1", "Y07494.1"], "translation": [{"protein": "CAA68793.1", "rna": "Y07494.1"}, {"protein": "BAG54347.1", "rna": "AK126573.1"}, {"protein": "BAG36951.1", "rna": "AK314296.1"}, {"protein": "BAG61427.1", "rna": "AK299460.1"}, {"protein": "AAA51799.1", "rna": "M16795.1"}, {"protein": "NP_000693.1", "rna": "NM_000702.4"}, {"protein": "AAX55909.1", "rna": "AY946014.1"}, {"protein": "XP_054192734.1", "rna": "XM_054336759.1"}, {"protein": "ALQ33386.1", "rna": "KU177928.1"}, {"protein": "BAG58570.1", "rna": "AK295729.1"}, {"protein": "BAG52393.1", "rna": "AK091617.1"}, {"protein": "XP_047277242.1", "rna": "XM_047421286.1"}, {"protein": "AAH52271.2", "rna": "BC052271.1"}, {"protein": "BAA34498.3", "rna": "AB018321.2"}, {"protein": "ALQ33385.1", "rna": "KU177927.1"}, {"protein": "BAG58098.1", "rna": "AK295048.1"}, {"protein": "BAG54055.1", "rna": "AK124581.1"}]}, "alias": ["DEE98", "FARIMPD", "FHM2", "MHP2"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2024-01-16T20:00:00.000Z", "disease_label": "hemiplegic migraine-developmental and epileptic encephalopathy spectrum", "gcep": "Epilepsy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0100539", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_fe788a45-b8da-4377-acdb-5dd55fcc3130-2024-01-16T200000.000Z", "sop": "SOP10"}}, "ec": "7.2.2.13", "ensembl": {"gene": "ENSG00000018625", "protein": ["ENSP00000354490", "ENSP00000376066", "ENSP00000411705"], "transcript": ["ENST00000361216", "ENST00000392233", "ENST00000447527", "ENST00000459972", "ENST00000463989", "ENST00000468587", "ENST00000472488", "ENST00000478587"], "translation": [{"protein": "ENSP00000354490", "rna": "ENST00000361216"}, {"protein": "ENSP00000376066", "rna": "ENST00000392233"}, {"protein": "ENSP00000411705", "rna": "ENST00000447527"}], "type_of_gene": "protein_coding"}, "entrezgene": "477", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 37.6334802577, "exp_mis": 409.254390061, "exp_syn": 184.954277806, "lof_z": 4.7850350928585, "mis_z": 5.39783714537521, "mu_lof": 2.64170160346e-06, "mu_mis": 3.67251781851e-05, "mu_syn": 1.60849118002e-05, "n_lof": 8.0, "n_mis": 186.0, "n_syn": 199.0, "p_li": 0.600219587089565, "p_null": 1.34447302186979e-07, "p_rec": 0.399780278463133, "syn_z": -0.640266285527123}, "bp": 3063, "cds_end": 160111112, "cds_start": 160085651, "n_exons": 23, "nonpsych": {"exp_lof": 33.6117795337, "exp_mis": 369.964573928, "exp_syn": 166.951309652, "lof_z": 5.01615213501665, "mis_z": 5.55833703887376, "mu_lof": 2.64170160346e-06, "mu_mis": 3.67251781851e-05, "mu_syn": 1.60849118002e-05, "n_lof": 4.0, "n_mis": 158.0, "n_syn": 177.0, "p_li": 0.996439605683741, "p_null": 4.78674528128443e-10, "p_rec": 0.00356039383758425, "syn_z": -0.489641784166471}, "nontcga": {"exp_lof": 34.5789250132, "exp_mis": 376.470187884, "exp_syn": 170.114056965, "lof_z": 4.62650258057171, "mis_z": 5.27586149919903, "mu_lof": 2.64170160346e-06, "mu_mis": 3.67251781851e-05, "mu_syn": 1.60849118002e-05, "n_lof": 7.0, "n_mis": 171.0, "n_syn": 183.0, "p_li": 0.721883477038672, "p_null": 2.10195308016359e-07, "p_rec": 0.27811631276602, "syn_z": -0.625557011986464}, "transcript": "ENST00000361216.3"}, "exons": [{"cdsend": 160141322, "cdsstart": 160115861, "chr": "1", "position": [[160115758, 160115873], [160120905, 160121010], [160121191, 160121251], [160123212, 160123416], [160123942, 160124056], [160124295, 160124430], [160125135, 160125253], [160127551, 160127820], [160128651, 160128850], [160128979, 160129089], [160129265, 160129400], [160130101, 160130291], [160130421, 160130597], [160134483, 160134620], [160135144, 160135295], [160135433, 160135602], [160135838, 160135993], [160136246, 160136370], [160136569, 160136715], [160136900, 160137031], [160139639, 160139741], [160139892, 160139984], [160141293, 160143584]], "strand": 1, "transcript": "NM_000702", "txend": 160143584, "txstart": 160115758}], "exons_hg19": [{"cdsend": 160111112, "cdsstart": 160085651, "chr": "1", "position": [[160085548, 160085663], [160090695, 160090800], [160090981, 160091041], [160093002, 160093206], [160093732, 160093846], [160094085, 160094220], [160094925, 160095043], [160097341, 160097610], [160098441, 160098640], [160098769, 160098879], [160099055, 160099190], [160099891, 160100081], [160100211, 160100387], [160104273, 160104410], [160104934, 160105085], [160105223, 160105392], [160105628, 160105783], [160106036, 160106160], [160106359, 160106505], [160106690, 160106821], [160109429, 160109531], [160109682, 160109774], [160111083, 160113374]], "strand": 1, "transcript": "NM_000702", "txend": 160113374, "txstart": 160085548}], "generif": [{"pubmed": 11257061, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12496141, "text": "fat mass, low-density lipoprotein cholesterol, and skeletal muscle glycolytic-to-oxidative enzyme ratio increased more in the alpha2-gene negative subjects with overfeeding, suggesting more unfavorable metabolic changes compared with the (+) subjects"}, {"pubmed": 12529322, "text": "Structural basis for alpha1 versus alpha2 isoform-distinct behavior of the Na,K-ATPase"}, {"pubmed": 12539047, "text": "Haploinsufficiency of atp1a2 encoding the Na+/K+ pump alpha2 subunit is associated with familial hemiplegic migraine type 2"}, {"pubmed": 12953268, "text": "novel missense mutations in the ATP1A2 Na(+),K(+)-ATPase pump gene on chromosome 1q23 in two families with familial hemiplegic migraine (FHM). affected family members with FHM, benign familial infantile convulsions, or both, carry the mutation"}, {"pubmed": 14685860, "text": "Patients with type 2 diabetes and controls were leg strength-trained for 30 min 3x per week for 6 weeks. In control subjects Na,K-pump alpha2 was increased by 21% in trained compared to untrained leg, and in diabetics alpha2 content was 41% higher."}, {"pubmed": 14690302, "text": "Elevated plasma cholesterol may be responsible for the inhibition of erythrocyte Na+-K+ ATPase activity"}, {"pubmed": 14871878, "text": "first direct evidence of differential transcriptional control of ATP1A2 gene in the kidney and colon"}, {"pubmed": 15133718, "text": "the T345A mutation co-segregated with hemiplegic migraine type 2 in our family and was not present in 132 healthy Finnish control individuals"}, {"pubmed": 15159495, "text": "3 putative A1A2 mutations (D718N, R763H, P979L) &3 that await validation (P796R, E902K, X1021R)were found in familial hemiplegic migraine.  D718N and P979L may predispose to seizures and mental retardation. A1A2 does not play a major role in sporadic HM."}, {"pubmed": 15174025, "text": "This study report a novel ATP1A2 mutation in a kindred with features that bridge the phenotypic spectrum between AHC and FHM syndromes, supporting a possible common pathogenesis in a subset of such cases."}, {"pubmed": 15210532, "text": "ATP1A2 gene is not associated with the more common migraine syndromes and is not one of the most common hemiplegic migraine genes."}, {"pubmed": 15286158, "text": "A novel ATP1A2 heterozygous missense mutation found in a family with multicase Alternating hemiplegia of childhood."}, {"pubmed": 15308625, "text": "Missense mutations in this enzyme subunit ause hemiplegic migraine."}, {"pubmed": 15459825, "text": "ATP1A2 mutation may have a role in familial hemiplegic migraine type 2 with cerebellar signs"}, {"pubmed": 15569317, "text": "The entire carboxy-terminus of HKalpha2 is required for stable assembly with beta1-Na+,K+-ATPase and functionality."}, {"pubmed": 15911117, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16026932, "text": "The ATP1A2 gene does not appear to be involved in the ethiopathogenesis of pure benign familial infantile seizures, at least in the explored Italian multiplex families"}, {"pubmed": 16037212, "text": "missense mutations R689Q and M731T in familial hemiplegic migraine type 2"}, {"pubmed": 16088919, "text": "analysis of ATP1A2 mutations in familial hemiplegic migraine"}, {"pubmed": 16110494, "text": "In conclusion we propose that rare variants in ATP1A2 are involved in the susceptibility to common forms of migraine."}, {"pubmed": 16344534, "text": "The authors detected a novel mutation in the ATP1A2 gene (R548H) in members of a family with BM, suggesting that BM and FHM may be allelic disorders."}, {"pubmed": 16430714, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16437583, "text": "This study identified a novel G615R ATP1A2 mutation in the proband and several of her family members. Functional analysis of mutant Na,K-ATPase in cellular survival assays showed a complete loss-of-function effect."}, {"pubmed": 16508934, "text": "Study shows that the ATP1A2 gene is probably not involved in migraine with aura."}, {"pubmed": 16508935, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16508935, "text": "Results showed no evidence for a common contribution of ATP1A2 to the pathogenesis of complex inherited migraine with aura."}, {"pubmed": 16538223, "text": "analysis of two novel de novo missense mutations in ATP1A2, R593W and V628M, associated with pure familial hemiplegic migraine"}, {"pubmed": 17119788, "text": "study to identify whether CACNA1A and ATP1A2 are or not related to Brazilian familial hemiplegic migraine"}, {"pubmed": 17446412, "text": "Elevated Na+ -K+ -ATPase activity postexercise may contribute to reduced fatigue after training."}, {"pubmed": 17473835, "text": "Compound heterozygote found in familial hemiplegic migraine."}, {"pubmed": 17727731, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17877748, "text": "confirm the involvement of ATP1A2 gene in the sporadic form of hemiplegic migraine"}, {"pubmed": 17952365, "text": "the recurrence of ATP1A2 mutations M731T and T376M that affect sodium-potassium pump functioning in two Portuguese FHM families"}, {"pubmed": 18028407, "text": "Novel ATP1A2 mutations were found in two of the 20 families (10%). The p.Gly900Arg mutation was present in a family with epilepsy and FHM, and the p.Cys702Tyr mutation occurred in a family with occipitotemporal epilepsy and migraine ."}, {"pubmed": 18028456, "text": "two novel ATP1A2 mutations that were identified in two Portuguese probands with hemiplegic migraine and interesting additional clinical features"}, {"pubmed": 18052210, "text": "reconstituted FXYD1 protects both alpha1beta1 and alpha2beta1 very strongly against thermal inactivation"}, {"pubmed": 18056581, "text": "Sequence variants were identified in seven SHM patients: one CACNA1A mutation, five ATP1A2 mutations, and one SCN1A polymorphism. All six mutations caused functional changes in cellular assays."}, {"pubmed": 18184292, "text": "D999H is a novel Hemiplegic Migraine, Familial ATP1A2 mutation in an Irish family."}, {"pubmed": 18294248, "text": "glyceryl trinitrate infusion failed to induce more migraine in FHM-2 patients than in controls"}, {"pubmed": 18451712, "text": "Nineteen novel ATP1A2 mutations were identified last year, eleven of them migraine families. A systematic genetic analysis of patients with sporadic hemiplegic migraine revealed five mutations in this gene [review]"}, {"pubmed": 18483709, "text": "In this study we document the absence of ATP1A2 mutations in two Italian sisters with menstrual BM, suggesting that other genes are involved in the condition."}, {"pubmed": 18498390, "text": "We studied four members of a family suffering from typical attacks of familial hemiplegic migraine (FHM) caused by a new mutation, R548C, of ATP1A2 gene in exon 12."}, {"pubmed": 18513263, "text": "4 new variants were found in exons of the ATP1A2 gene in sporadic hemiplegic migraine patients. It does not seem that ATP1A2 is a major gene in SHM."}, {"pubmed": 18513263, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18644608, "text": "A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures."}, {"pubmed": 18728015, "text": "Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2.("}, {"pubmed": 18811707, "text": "the T378N mutation was not found in in five patients with alternating hemiplegia of childhood"}, {"pubmed": 18957371, "text": "Several mutations in alpha2 have been identified that link the specific function of the Na+,K+-ATPase to the pathophysiology of neurological diseases such as rapid-onset dystonia parkinsonism and familial hemiplegic migraine type 2"}, {"pubmed": 19007941, "text": "familial hemiplegic migraine 3 is a high resistant molecule when compared to FHM1 and FHM2"}, {"pubmed": 19058785, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19058785, "text": "Significant nominal association with bipolar disooder was observed for single Single Nucleotide Polymorphism(rs2070704, rs1016732, rs2854248, and rs2295623) in the gene of ATP1A2."}, {"pubmed": 19199261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19199261, "text": "The rs4961 polymorphism of the ADD1 gene is associated with essential hypertension, but the rs28933400 locus in the ATP1A2 gene may have no association with essential hypertension in the studied population."}, {"pubmed": 19372756, "text": "functional data on a set of ATP1A2 mutations (G301R, R908Q and P979L) reveal temperature-sensitive effects on protein stability can underlie ATP1A2 loss-of-function"}, {"pubmed": 19638348, "text": "Data show that PLM associates with and modulates both NKA-alpha1 and NKA-alpha2 in a comparable but not identical manner."}, {"pubmed": 19751721, "text": "Cardiac glycosides show distinct isoform specific affinities and different affinity profiles to Na(+),K(+)-ATPase isoforms which have different subcellular localizations in human cardiomyocytes."}, {"pubmed": 19874388, "text": "study investigated the molecular basis of febrile seizures in a small family with co-occurring hemiplegic migraine & febrile seizures; findings indicate ATP1A2 p.Gly855Arg mutation is the causal mutation in this family"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20100892, "text": "deletion of two tyrosines at the carboxy terminus of the human Na(+)/K(+)-ATPase alpha(2) subunit decreases the affinity for extracellular and intracellular Na(+)."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20720542, "text": "Using the human alpha2 isoform, a novel model for ion transport by the Na+/K+-ATPase is established by electrophysiological studies of C-terminal mutations in familial hemiplegic migraine 2."}, {"pubmed": 20837964, "text": "ATP1A2 gene is involved in early-onset sporadic hemiplegic migraine, in particular when associated with neurologic signs"}, {"pubmed": 20936682, "text": "Altered dopamine signaling in Na,K-ATPasealpha2 transgenic mice contributes to reduced startle reactivity, lack of habituation, disruption of navigational circuitry, and impaired egocentric learning."}, {"pubmed": 20952631, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21398422, "text": "Na(+)/K(+)-ATPase haploinsufficiency caused by the ATP1A2 p.G301R mutation is responsible for familial hemiplegic migraine in the described family."}, {"pubmed": 21533730, "text": "these results demonstrate a more frequent involvement of the ATP1A2 gene in the sporadic as well as familial forms of hemiplegic migraine in Italian patients without permanent cerebellar signs"}, {"pubmed": 22013243, "text": "cerebral blood flow changes during attacks of hemiplegic migraine with prolonged aura longer than 24 h in patients with familial hemiplegic migraine with a novel gene mutation; authors identified a novel heterozygous p.H916L mutation in the ATP1A2 gene in all three individuals in the family"}, {"pubmed": 22117059, "text": "Inhibition of phosphorylation of na+,k+-ATPase by mutations causing familial hemiplegic migraine."}, {"pubmed": 22433860, "text": "Data show that protein kinase A (PKA) phosphorylation has a drastic impact on Na(+)/K(+)-ATPase (NKA) structure and dynamics."}, {"pubmed": 22565168, "text": "Data show that Na(+),K(+)-ATPase activity was >50% lower and membrane-associated tubulin content was >200% higher in erythrocyte membranes from diabetic patients."}, {"pubmed": 22661290, "text": "examined a family with a FHM phenotype due to a M731T mutation in ATP1A2. A 10-year follow-up allowed us to observe complex auras, including psychotic symptoms in two siblings"}, {"pubmed": 22936730, "text": "Skeletal muscle in elderly individuals was characterized by decreased NKA alpha(2) protein abundance, but unchanged [(3)H]ouabain binding."}, {"pubmed": 23474907, "text": "Data indicate that (4-Chloro-2-(piperidin-1-yl)thiazol-5-yl)(phenyl)methanone and (4-bromo-2-(piperidin-1-yl)thiazol-5-yl)(phenyl)methanone inhibited cell growth through inhibition of both alpha-1 Na(+)/K(+)-ATPase (NAK) and Ras oncogene activity."}, {"pubmed": 23821026, "text": "genetic testing showed a mutation in the ATP1A2 gene OF two patients suffering from migraine with aura since youth"}, {"pubmed": 23838748, "text": "We describe a four-generation Italian family with familial hemiplegic migraine (FHM) and epilepsy due to a novel ATP1A2 missense mutation"}, {"pubmed": 23918834, "text": "The present study provides further evidence on the involvement of ATP1A2 mutations in both migraine and epilepsy, underlying the relevance of genetic analysis in families with a comorbidity of both disorders."}, {"pubmed": 23954377, "text": "ATP1A2 missense mutations are associated with familial hemiplegic migraine."}, {"pubmed": 24096472, "text": "Three patients with a proven mutation in the ATP1A2 gene clinically presented without hemiparesis."}, {"pubmed": 24097848, "text": "Identification of a novel heterozygous mutation in the ATP1A2 gene (c.1766T>C, Ile589Thr) causing atypical alternating hemiplegia of childhood in a Saudi consanguineous family"}, {"pubmed": 24136331, "text": "mutations in the ATP1A2 gene might contribute to pulmonary arterial remodelling and pulmonary arterial hypertension"}, {"pubmed": 24286483, "text": "genome-wide linkage analysis of the migraine phenotype in 38 families with Rolandic epilepsy; evidence found of linkage to migraine at chromosome 17q12-22 and suggestive evidence at 1q23.1-23.2, centering over the FHM2 locus"}, {"pubmed": 24356962, "text": "Relationship between intracellular Na+ concentration and reduced Na+ affinity in Na+,K+-ATPase mutants causing neurological disease"}, {"pubmed": 24928127, "text": "In this family, benign familial infantile seizures (BFIS) are caused by a PRRT2 mutation and hemiplegic migraine by p.Arg689Gln ATPase ATP1A2 mutation."}, {"pubmed": 25138102, "text": "A missense variant of the ATP1A2 gene is associated with a novel phenotype of progressive sensorineural hearing loss associated with migraine"}, {"pubmed": 25713066, "text": "Data indicate that a second-site mutation distant from Na+ site III increases Na+ affinity, Na(+),K(+)-ATPase activity, and cellular K+ uptake in mutants with the replacement of the aspartate."}, {"pubmed": 25994790, "text": "Report tumor cell sensitivity to cardiac glycosides depends on pattern of expression of alpha1-, alpha2-, or alpha3-isoforms of Na-K-ATPase."}, {"pubmed": 26747084, "text": "On the other hand, the presence of KCNK18 mutation indicated another FHM subtype."}, {"pubmed": 27226003, "text": "A novel p.Arg348Pro ATP1A2 mutation was found in 14 family members: 12 with clinical familial hemiplegic migraine (FHM), one with psychomotor retardation and possible FHM, and one without FHM features"}, {"pubmed": 29486580, "text": "We have shown that mutations in CACNA1A, ATP1A2 and SCN1A are not the major cause of the disease in Finnish hemiplegic migraine patients"}, {"pubmed": 29904856, "text": "The sporadic hemiplegic migraine is caused mutation of ATP1A2 gene."}, {"pubmed": 30423015, "text": "Data implicate ATP1A2 as a new hypokalaemic periodic paralysis gene and leak currents as a common pathomechanism of hypokalaemic periodic paralysis."}, {"pubmed": 30690204, "text": "Biallelic loss of function variants in ATP1A2 cause hydrops fetalis, microcephaly, arthrogryposis and extensive cortical malformations."}, {"pubmed": 31053037, "text": "A Chinese family with familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2."}, {"pubmed": 31980564, "text": "Higher burden of rare frameshift indels in genes related to synaptic transmission separate familial hemiplegic migraine from common types of migraine."}, {"pubmed": 32484063, "text": "Characteristics of cortical spreading depression and c-Fos expression in transgenic mice having a mutation associated with familial hemiplegic migraine 2."}, {"pubmed": 33493807, "text": "Early onset severe ATP1A2 epileptic encephalopathy: Clinical characteristics and underlying mutations."}, {"pubmed": 33578253, "text": "A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patients."}, {"pubmed": 33711927, "text": "Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2."}, {"pubmed": 33880529, "text": "ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria."}, {"pubmed": 34092402, "text": "Hemiplegic migraine type 2 caused by a novel variant within the P-type ATPase motif in ATP1A2 concomitant with a CACNA1A variant."}, {"pubmed": 34384358, "text": "Functional correlation of ATP1A2 mutations with phenotypic spectrum: from pure hemiplegic migraine to its variant forms."}, {"pubmed": 35257835, "text": "Hemiplegic migraine type 2 with new mutation of the ATP1A2 gene in Japanese cases."}, {"pubmed": 37142513, "text": "The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients."}], "genomic_pos": {"chr": "1", "end": 160143591, "ensemblgene": "ENSG00000018625", "start": 160115759, "strand": 1}, "genomic_pos_hg19": {"chr": "1", "end": 160113381, "start": 160085549, "strand": 1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0001504", "qualifier": "involved_in", "term": "neurotransmitter uptake"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001662", "qualifier": "acts_upstream_of_or_within", "term": "behavioral fear response"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0002026", "qualifier": "acts_upstream_of_or_within", "term": "regulation of the force of heart contraction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0002087", "qualifier": "acts_upstream_of_or_within", "term": "regulation of respiratory gaseous exchange by nervous system process"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006813", "pubmed": 10642400, "qualifier": "involved_in", "term": "potassium ion transport"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006814", "pubmed": 10642400, "qualifier": "involved_in", "term": "sodium ion transport"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006883", "qualifier": "involved_in", "term": "intracellular sodium ion homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006883", "pubmed": 10636900, "qualifier": "involved_in", "term": "intracellular sodium ion homeostasis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0006937", "qualifier": "acts_upstream_of_or_within", "term": "regulation of muscle contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006940", "qualifier": "involved_in", "term": "regulation of smooth muscle contraction"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0006942", "pubmed": 10642400, "qualifier": "involved_in", "term": "regulation of striated muscle contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008217", "qualifier": "involved_in", "term": "regulation of blood pressure"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008344", "qualifier": "involved_in", "term": "adult locomotory behavior"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008542", "qualifier": "involved_in", "term": "visual learning"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0010248", "qualifier": "involved_in", "term": "establishment or maintenance of transmembrane electrochemical gradient"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0010881", "pubmed": 23608603, "qualifier": "involved_in", "term": "regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0010996", "qualifier": "involved_in", "term": "response to auditory stimulus"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019227", "qualifier": "involved_in", "term": "neuronal action potential propagation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019229", "qualifier": "involved_in", "term": "regulation of vasoconstriction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0019852", "qualifier": "involved_in", "term": "L-ascorbic acid metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021764", "qualifier": "acts_upstream_of_or_within", "term": "amygdala development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0021989", "qualifier": "acts_upstream_of_or_within", "term": "olfactory cortex development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030007", "qualifier": "involved_in", "term": "intracellular potassium ion homeostasis"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0030007", "pubmed": 23954377, "qualifier": "involved_in", "term": "intracellular potassium ion homeostasis"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0030007", "pubmed": 10636900, "qualifier": "involved_in", "term": "intracellular potassium ion homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035094", "qualifier": "involved_in", "term": "response to nicotine"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035641", "qualifier": "involved_in", "term": "locomotory exploration behavior"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0035725", "pubmed": 18728015, "qualifier": "involved_in", "term": "sodium ion transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035864", "qualifier": "involved_in", "term": "response to potassium ion"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0036376", "qualifier": "involved_in", "term": "sodium ion export across plasma membrane"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0036376", "pubmed": 10636900, "qualifier": "involved_in", "term": "sodium ion export across plasma membrane"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0040011", "qualifier": "acts_upstream_of_or_within", "term": "locomotion"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045822", "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of heart contraction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045823", "qualifier": "acts_upstream_of_or_within", "term": "positive regulation of heart contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045988", "qualifier": "involved_in", "term": "negative regulation of striated muscle contraction"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046034", "pubmed": 23954377, "qualifier": "involved_in", "term": "ATP metabolic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0051481", "qualifier": "acts_upstream_of_or_within", "term": "negative regulation of cytosolic calcium ion concentration"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0051946", "pubmed": 23954377, "qualifier": "involved_in", "term": "regulation of glutamate uptake involved in transmission of nerve impulse"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0051966", "pubmed": 23954377, "qualifier": "involved_in", "term": "regulation of synaptic transmission, glutamatergic"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0055119", "pubmed": 23224879, "qualifier": "involved_in", "term": "relaxation of cardiac muscle"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0060048", "pubmed": 23224879, "qualifier": "involved_in", "term": "cardiac muscle contraction"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071260", "qualifier": "involved_in", "term": "cellular response to mechanical stimulus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0071383", "pubmed": 14742675, "qualifier": "involved_in", "term": "cellular response to steroid hormone stimulus"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0071805", "pubmed": 18728015, "qualifier": "involved_in", "term": "potassium ion transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0086004", "qualifier": "involved_in", "term": "regulation of cardiac muscle cell contraction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0086009", "pubmed": 23954377, "qualifier": "involved_in", "term": "membrane repolarization"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0086012", "pubmed": 23608603, "qualifier": "involved_in", "term": "membrane depolarization during cardiac muscle cell action potential"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0086064", "pubmed": 19683723, "qualifier": "involved_in", "term": "cell communication by electrical coupling involved in cardiac conduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0098655", "pubmed": 19372756, "qualifier": "involved_in", "term": "monoatomic cation transmembrane transport"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0098655", "pubmed": 20100892, "qualifier": "involved_in", "term": "monoatomic cation transmembrane transport"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0150104", "pubmed": 30280653, "qualifier": "involved_in", "term": "transport across blood-brain barrier"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1902600", "qualifier": "involved_in", "term": "proton transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903170", "qualifier": "involved_in", "term": "negative regulation of calcium ion transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903280", "qualifier": "involved_in", "term": "negative regulation of calcium:sodium antiporter activity"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:1903416", "pubmed": 14742675, "qualifier": "involved_in", "term": "response to glycoside"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903416", "qualifier": "involved_in", "term": "response to glycoside"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1990573", "qualifier": "involved_in", "term": "potassium ion import across plasma membrane"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:1990573", "pubmed": 23954377, "qualifier": "involved_in", "term": "potassium ion import across plasma membrane"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1990573", "pubmed": 10636900, "qualifier": "involved_in", "term": "potassium ion import across plasma membrane"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 12539047, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005768", "qualifier": "located_in", "term": "endosome"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005783", "qualifier": "located_in", "term": "endoplasmic reticulum"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 12539047, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IGI", "gocategory": "CC", "id": "GO:0005886", "pubmed": [19372756, 19751721], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005890", "qualifier": "part_of", "term": "sodium:potassium-exchanging ATPase complex"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005890", "pubmed": 12539047, "qualifier": "part_of", "term": "sodium:potassium-exchanging ATPase complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005890", "pubmed": [10636900, 23954377], "qualifier": "part_of", "term": "sodium:potassium-exchanging ATPase complex"}, {"evidence": "IGI", "gocategory": "CC", "id": "GO:0005890", "pubmed": [18052210, 18728015], "qualifier": "part_of", "term": "sodium:potassium-exchanging ATPase complex"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005890", "qualifier": "part_of", "term": "sodium:potassium-exchanging ATPase complex"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005901", "qualifier": "located_in", "term": "caveola"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0009986", "qualifier": "located_in", "term": "cell surface"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0014704", "qualifier": "located_in", "term": "intercalated disc"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0016020", "pubmed": 23954377, "qualifier": "located_in", "term": "membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0016020", "qualifier": "located_in", "term": "membrane"}, {"evidence": "IGI", "gocategory": "CC", "id": "GO:0030315", "pubmed": 19751721, "qualifier": "located_in", "term": "T-tubule"}, {"evidence": "IGI", "gocategory": "CC", "id": "GO:0031090", "pubmed": 19751721, "qualifier": "located_in", "term": "organelle membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0042995", "qualifier": "is_active_in", "term": "cell projection"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0042995", "qualifier": "located_in", "term": "cell projection"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0043025", "qualifier": "located_in", "term": "neuronal cell body"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0043197", "qualifier": "located_in", "term": "dendritic spine"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:1903561", "pubmed": 24769233, "qualifier": "located_in", "term": "extracellular vesicle"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005391", "qualifier": "enables", "term": "P-type sodium:potassium-exchanging transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005391", "pubmed": 10636900, "qualifier": "enables", "term": "P-type sodium:potassium-exchanging transporter activity"}, {"category": "MF", "evidence": "IGI", "id": "GO:0005391", "pubmed": [18052210, 18728015, 20100892], "qualifier": "enables", "term": "P-type sodium:potassium-exchanging transporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0005391", "pubmed": [12539047, 23954377], "qualifier": "enables", "term": "P-type sodium:potassium-exchanging transporter activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0005391", "qualifier": "enables", "term": "P-type sodium:potassium-exchanging transporter activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005496", "pubmed": 23954377, "qualifier": "enables", "term": "steroid binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 23954377, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0005524", "pubmed": 23954377, "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0016791", "qualifier": "enables", "term": "phosphatase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0016887", "pubmed": 23954377, "qualifier": "enables", "term": "ATP hydrolysis activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0019829", "pubmed": 19372756, "qualifier": "enables", "term": "ATPase-coupled monoatomic cation transmembrane transporter activity"}, {"category": "MF", "evidence": "IGI", "id": "GO:0019829", "pubmed": 20100892, "qualifier": "enables", "term": "ATPase-coupled monoatomic cation transmembrane transporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0030955", "pubmed": 23954377, "qualifier": "enables", "term": "potassium ion binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0031402", "pubmed": 23954377, "qualifier": "enables", "term": "sodium ion binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0046982", "qualifier": "enables", "term": "protein heterodimerization activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0051087", "pubmed": 10636900, "qualifier": "enables", "term": "protein-folding chaperone binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990239", "pubmed": 14742675, "qualifier": "enables", "term": "steroid hormone binding"}]}, "homologene": {"genes": [[7955, 64609], [8364, 100125050], [9031, 396468], [9544, 720191], [9598, 457432], [9606, 477], [9615, 488636], [9913, 515161], [10090, 98660], [10116, 24212], [318829, 2680984], [318829, 12986277]], "id": 47947}, "interpro": [{"desc": "P-type ATPase", "id": "IPR001757", "short_desc": "P_typ_ATPase"}, {"desc": "Cation-transporting P-type ATPase, N-terminal", "id": "IPR004014", "short_desc": "ATPase_P-typ_cation-transptr_N"}, {"desc": "P-type ATPase subfamily IIC, subunit alpha", "id": "IPR005775", "short_desc": "P-type_ATPase_IIC"}, {"desc": "Cation-transporting P-type ATPase, C-terminal", "id": "IPR006068", "short_desc": "ATPase_P-typ_cation-transptr_C"}, {"desc": "P-type ATPase, A domain superfamily", "id": "IPR008250", "short_desc": "ATPase_P-typ_transduc_dom_A_sf"}, {"desc": "P-type ATPase, phosphorylation site", "id": "IPR018303", "short_desc": "ATPase_P-typ_P_site"}, {"desc": "HAD superfamily", "id": "IPR023214", "short_desc": "HAD_sf"}, {"desc": "P-type ATPase, transmembrane domain superfamily", "id": "IPR023298", "short_desc": "ATPase_P-typ_TM_dom_sf"}, {"desc": "P-type ATPase, cytoplasmic domain N", "id": "IPR023299", "short_desc": "ATPase_P-typ_cyto_dom_N"}, {"desc": "HAD-like superfamily", "id": "IPR036412", "short_desc": "HAD-like_sf"}, {"desc": "P-type ATPase, haloacid dehalogenase domain", "id": "IPR044492", "short_desc": "P_typ_ATPase_HD_dom"}], "ipi": ["IPI00003021", "IPI00640401", "IPI00908591"], "map_location": "1q23.2", "name": "ATPase Na+/K+ transporting subunit alpha 2", "other_names": ["ATPase Na+/K+ transporting alpha 2 polypeptide", "Na(+)/K(+) ATPase alpha-2 subunit", "Na+/K+ ATPase, alpha-A(+) catalytic polypeptide", "Na+/K+ ATPase, alpha-B polypeptide", "sodium pump subunit alpha-2", "sodium-potassium ATPase catalytic subunit alpha-2", "sodium/potassium-transporting ATPase alpha-2 chain", "sodium/potassium-transporting ATPase subunit alpha-2"], "pantherdb": {"HGNC": "800", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88106", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 10090, "uniprot_kb": "Q6PIE5"}, {"RGD": "2168", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 10116, "uniprot_kb": "P06686"}, {"Ensembl": "ENSGALG00000048440", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 9031, "uniprot_kb": "A0A3Q2UB34"}, {"Gene": "ATP1A2", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 9031, "uniprot_kb": "P24797"}, {"ZFIN": "ZDB-GENE-001212-6", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 7955, "uniprot_kb": "B0S5Q5"}, {"WormBase": "WBGene00007248", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 6239, "uniprot_kb": "G5EFV6"}, {"WormBase": "WBGene00015338", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 6239, "uniprot_kb": "O16436"}, {"WormBase": "WBGene00015660", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 6239, "uniprot_kb": "O16331"}, {"WormBase": "WBGene00013672", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 6239, "uniprot_kb": "G5EBE7"}, {"WormBase": "WBGene00001137", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 6239, "uniprot_kb": "P90735"}, {"FlyBase": "FBgn0267363", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 7227, "uniprot_kb": "A8QI34"}, {"FlyBase": "FBgn0266432", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 7227, "uniprot_kb": "A0A0B4LG94"}, {"FlyBase": "FBgn0002921", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 7227, "uniprot_kb": "P13607"}, {"dictyBase": "DDB_G0277269", "ortholog_type": "O", "panther_family": "PTHR43294", "taxid": 352472, "uniprot_kb": "Q76P11"}, {"dictyBase": "DDB_G0267924", "ortholog_type": "LDO", "panther_family": "PTHR43294", "taxid": 352472, "uniprot_kb": "Q55FW3"}], "uniprot_kb": "P50993"}, "pathway": {"kegg": [{"id": "hsa04022", "name": "cGMP-PKG signaling pathway - Homo sapiens (human)"}, {"id": "hsa04024", "name": "cAMP signaling pathway - Homo sapiens (human)"}, {"id": "hsa04260", "name": "Cardiac muscle contraction - Homo sapiens (human)"}, {"id": "hsa04261", "name": "Adrenergic signaling in cardiomyocytes - Homo sapiens (human)"}, {"id": "hsa04911", "name": "Insulin secretion - Homo sapiens (human)"}, {"id": "hsa04918", "name": "Thyroid hormone synthesis - Homo sapiens (human)"}, {"id": "hsa04919", "name": "Thyroid hormone signaling pathway - Homo sapiens (human)"}, {"id": "hsa04925", "name": "Aldosterone synthesis and secretion - Homo sapiens (human)"}, {"id": "hsa04960", "name": "Aldosterone-regulated sodium reabsorption - Homo sapiens (human)"}, {"id": "hsa04961", "name": "Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human)"}, {"id": "hsa04964", "name": "Proximal tubule bicarbonate reclamation - Homo sapiens (human)"}, {"id": "hsa04970", "name": "Salivary secretion - Homo sapiens (human)"}, {"id": "hsa04971", "name": "Gastric acid secretion - Homo sapiens (human)"}, {"id": "hsa04972", "name": "Pancreatic secretion - Homo sapiens (human)"}, {"id": "hsa04973", "name": "Carbohydrate digestion and absorption - Homo sapiens (human)"}, {"id": "hsa04974", "name": "Protein digestion and absorption - Homo sapiens (human)"}, {"id": "hsa04976", "name": "Bile secretion - Homo sapiens (human)"}, {"id": "hsa04978", "name": "Mineral absorption - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-397014", "name": "Muscle contraction"}, {"id": "R-HSA-5576891", "name": "Cardiac conduction"}, {"id": "R-HSA-5578775", "name": "Ion homeostasis"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-936837", "name": "Ion transport by P-type ATPases"}, {"id": "R-HSA-9679191", "name": "Potential therapeutics for SARS"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-983712", "name": "Ion channel transport"}], "smpdb": [{"id": "SMP00078", "name": "Chlorothiazide Action Pathway"}, {"id": "SMP00080", "name": "Polythiazide Action Pathway"}, {"id": "SMP00081", "name": "Methyclothiazide Action Pathway"}, {"id": "SMP00088", "name": "Bumetanide Action Pathway"}, {"id": "SMP00090", "name": "Bendroflumethiazide Action Pathway"}, {"id": "SMP00091", "name": "Quinethazone Action Pathway"}, {"id": "SMP00097", "name": "Ethacrynic Acid Action Pathway"}, {"id": "SMP00100", "name": "Hydrochlorothiazide Action Pathway"}, {"id": "SMP00103", "name": "Cyclothiazide Action Pathway"}, {"id": "SMP00105", "name": "Metolazone Action Pathway"}, {"id": "SMP00108", "name": "Hydroflumethiazide Action Pathway"}, {"id": "SMP00110", "name": "Indapamide Action Pathway"}, {"id": "SMP00115", "name": "Furosemide Action Pathway"}, {"id": "SMP00118", "name": "Torsemide Action Pathway"}, {"id": "SMP00121", "name": "Trichlormethiazide Action Pathway"}, {"id": "SMP00122", "name": "Chlorthalidone Action Pathway"}, {"id": "SMP00132", "name": "Triamterene Action Pathway"}, {"id": "SMP00133", "name": "Amiloride Action Pathway"}, {"id": "SMP00134", "name": "Spironolactone Action Pathway"}, {"id": "SMP00135", "name": "Eplerenone Action Pathway"}, {"id": "SMP00184", "name": "Glucose Transporter Defect (SGLT2)"}, {"id": "SMP00189", "name": "Hartnup Disorder"}, {"id": "SMP00193", "name": "Iminoglycinuria"}, {"id": "SMP00197", "name": "Lysinuric Protein Intolerance"}, {"id": "SMP00245", "name": "Glucose Transporter Defect (SGLT2)"}, {"id": "SMP00296", "name": "Acebutolol Action Pathway"}, {"id": "SMP00297", "name": "Alprenolol Action Pathway"}, {"id": "SMP00298", "name": "Atenolol Action Pathway"}, {"id": "SMP00299", "name": "Betaxolol Action Pathway"}, {"id": "SMP00300", "name": "Bisoprolol Action Pathway"}, {"id": "SMP00301", "name": "Esmolol Action Pathway"}, {"id": "SMP00302", "name": "Metoprolol Action Pathway"}, {"id": "SMP00303", "name": "Nadolol Action Pathway"}, {"id": "SMP00304", "name": "Oxprenolol Action Pathway"}, {"id": "SMP00305", "name": "Penbutolol Action Pathway"}, {"id": "SMP00306", "name": "Pindolol Action Pathway"}, {"id": "SMP00307", "name": "Propranolol Action Pathway"}, {"id": "SMP00323", "name": "Quinidine Action Pathway"}, {"id": "SMP00324", "name": "Procainamide (Antiarrhythmic) Action Pathway"}, {"id": "SMP00325", "name": "Disopyramide Action Pathway"}, {"id": "SMP00326", "name": "Fosphenytoin (Antiarrhythmic) Action Pathway"}, {"id": "SMP00327", "name": "Phenytoin (Antiarrhythmic) Action Pathway"}, {"id": "SMP00328", "name": "Lidocaine (Antiarrhythmic) Action Pathway"}, {"id": "SMP00329", "name": "Mexiletine Action Pathway"}, {"id": "SMP00330", "name": "Tocainide Action Pathway"}, {"id": "SMP00331", "name": "Flecainide Action Pathway"}, {"id": "SMP00332", "name": "Ibutilide Action Pathway"}, {"id": "SMP00359", "name": "Diltiazem Action Pathway"}, {"id": "SMP00366", "name": "Nebivolol Action Pathway"}, {"id": "SMP00367", "name": "Carvedilol Action Pathway"}, {"id": "SMP00368", "name": "Labetalol Action Pathway"}, {"id": "SMP00375", "name": "Verapamil Action Pathway"}, {"id": "SMP00376", "name": "Amlodipine Action Pathway"}, {"id": "SMP00377", "name": "Felodipine Action Pathway"}, {"id": "SMP00378", "name": "Isradipine Action Pathway"}, {"id": "SMP00379", "name": "Nifedipine Action Pathway"}, {"id": "SMP00380", "name": "Nimodipine Action Pathway"}, {"id": "SMP00381", "name": "Nisoldipine Action Pathway"}, {"id": "SMP00382", "name": "Nitrendipine Action Pathway"}, {"id": "SMP00392", "name": "Benzocaine Action Pathway"}, {"id": "SMP00393", "name": "Bupivacaine Action Pathway"}, {"id": "SMP00394", "name": "Chloroprocaine Action Pathway"}, {"id": "SMP00395", "name": "Cocaine Action Pathway"}, {"id": "SMP00396", "name": "Dibucaine Action Pathway"}, {"id": "SMP00397", "name": "Levobupivacaine Action Pathway"}, {"id": "SMP00398", "name": "Lidocaine (Local Anaesthetic) Action Pathway"}, {"id": "SMP00399", "name": "Mepivacaine Action Pathway"}, {"id": "SMP00400", "name": "Oxybuprocaine Action Pathway"}, {"id": "SMP00401", "name": "Prilocaine Action Pathway"}, {"id": "SMP00402", "name": "Procaine Action Pathway"}, {"id": "SMP00403", "name": "Proparacaine Action Pathway"}, {"id": "SMP00404", "name": "Ropivacaine Action Pathway"}, {"id": "SMP00405", "name": "Codeine Action Pathway"}, {"id": "SMP00406", "name": "Morphine Action Pathway"}, {"id": "SMP00407", "name": "Heroin Action Pathway"}, {"id": "SMP00408", "name": "Methadone Action Pathway"}, {"id": "SMP00409", "name": "Oxycodone Action Pathway"}, {"id": "SMP00410", "name": "Hydromorphone Action Pathway"}, {"id": "SMP00411", "name": "Hydrocodone Action Pathway"}, {"id": "SMP00412", "name": "Oxymorphone Action Pathway"}, {"id": "SMP00413", "name": "Alfentanil Action Pathway"}, {"id": "SMP00414", "name": "Carfentanil Action Pathway"}, {"id": "SMP00415", "name": "Fentanyl Action Pathway"}, {"id": "SMP00416", "name": "Remifentanil Action Pathway"}, {"id": "SMP00417", "name": "Sufentanil Action Pathway"}, {"id": "SMP00422", "name": "Imipramine Action Pathway"}, {"id": "SMP00423", "name": "Desipramine Action Pathway"}, {"id": "SMP00424", "name": "Citalopram Action Pathway"}, {"id": "SMP00425", "name": "Escitalopram Action Pathway"}, {"id": "SMP00426", "name": "Fluoxetine Action Pathway"}, {"id": "SMP00431", "name": "Nicotine Action Pathway"}, {"id": "SMP00457", "name": "Lactose Degradation"}, {"id": "SMP00458", "name": "Lactose Intolerance"}, {"id": "SMP00467", "name": "Trehalose Degradation"}, {"id": "SMP00483", "name": "Kidney Function"}, {"id": "SMP00583", "name": "Blue diaper syndrome"}, {"id": "SMP00585", "name": "Lysinuric protein intolerance (LPI)"}, {"id": "SMP00588", "name": "Muscle/Heart Contraction"}, {"id": "SMP00657", "name": "Bopindolol Action Pathway"}, {"id": "SMP00658", "name": "Carteolol Action Pathway"}, {"id": "SMP00659", "name": "Timolol Action Pathway"}, {"id": "SMP00660", "name": "Sotalol Action Pathway"}, {"id": "SMP00661", "name": "Epinephrine Action Pathway"}, {"id": "SMP00662", "name": "Dobutamine Action Pathway"}, {"id": "SMP00663", "name": "Isoprenaline Action Pathway"}, {"id": "SMP00664", "name": "Arbutamine Action Pathway"}, {"id": "SMP00665", "name": "Amiodarone Action Pathway"}, {"id": "SMP00666", "name": "Levobunolol Action Pathway"}, {"id": "SMP00667", "name": "Metipranolol Action Pathway"}, {"id": "SMP00668", "name": "Bevantolol Action Pathway"}, {"id": "SMP00669", "name": "Practolol Action Pathway"}, {"id": "SMP00670", "name": "Bupranolol Action Pathway"}, {"id": "SMP00671", "name": "Tramadol Action Action Pathway"}, {"id": "SMP00672", "name": "Propoxyphene Action Pathway"}, {"id": "SMP00673", "name": "Levorphanol Action Pathway"}, {"id": "SMP00674", "name": "Anileridine Action Pathway"}, {"id": "SMP00675", "name": "Diphenoxylate Action Pathway"}, {"id": "SMP00676", "name": "Dezocine Action Pathway"}, {"id": "SMP00677", "name": "Levomethadyl Acetate Action Action Pathway"}, {"id": "SMP00678", "name": "Methadyl Acetate Action Pathway"}, {"id": "SMP00679", "name": "3-Methylthiofentanyl Action Pathway"}, {"id": "SMP00680", "name": "Dimethylthiambutene Action Pathway"}, {"id": "SMP00681", "name": "Ethylmorphine Action Pathway"}, {"id": "SMP00683", "name": "Levallorphan Action Pathway"}, {"id": "SMP00684", "name": "Buprenorphine Action Pathway"}, {"id": "SMP00685", "name": "Alvimopan Action Pathway"}, {"id": "SMP00686", "name": "Pentazocine Action Pathway"}, {"id": "SMP00687", "name": "Naltrexone Action Pathway"}, {"id": "SMP00688", "name": "Naloxone Action Pathway"}, {"id": "SMP00689", "name": "Dihydromorphine Action Pathway"}, {"id": "SMP00690", "name": "Ketobemidone  Action Pathway"}, {"id": "SMP00691", "name": "Nalbuphine Action Pathway"}, {"id": "SMP00723", "name": "Cystinuria"}], "wikipathways": {"id": "WP2267", "name": "Synaptic Vesicle Pathway"}}, "pfam": ["PF00122", "PF00689", "PF00690", "PF00702", "PF13246"], "pharmgkb": "PA30796", "pharos": {"target_id": 8744, "tdl": "Tclin"}, "pir": "A34474", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF246083", "relationship": "is"}, {"id": "GNF246084", "relationship": "is"}, {"id": "GNF246085", "relationship": "is"}, {"id": "GNF246086", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF031373", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079850", "relationship": "is"}, {"id": "GNF079851", "relationship": "is"}, {"id": "GNF079852", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053828", "relationship": "is"}, {"id": "GNF058603", "relationship": "is"}, {"id": "GNF073849", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF068197", "relationship": "is"}, {"id": "GNF068198", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF000859", "relationship": "is"}}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1", "NG_008014.1"], "protein": ["NP_000693.1", "XP_047277242.1", "XP_054192734.1"], "rna": ["NM_000702.4", "XM_047421286.1", "XM_054336759.1"], "translation": [{"protein": "XP_047277242.1", "rna": "XM_047421286.1"}, {"protein": "NP_000693.1", "rna": "NM_000702.4"}, {"protein": "XP_054192734.1", "rna": "XM_054336759.1"}]}, "reporter": {"HG-U133_Plus_2": ["203295_s_at", "203296_s_at"], "HG-U95Av2": "34377_at", "HTA-2_0": "TC01001361.hg.1", "HuEx-1_0": ["2362892", "2816485"], "HuGene-1_1": "7906501", "HuGene-2_1": "16672505"}, "retired": [4262, 82820, 93186, 113143, 116200, 127374, 148944, 337931], "summary": "The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008].", "symbol": "ATP1A2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412629"}, "unigene": "Hs.34114", "uniprot": {"Swiss-Prot": "P50993", "TrEMBL": ["H0Y7C1", "A0A0S2Z3W6", "B1AKY9"]}, "wikipedia": {"url_stub": "ATP1A2"}}